Noom Introduces Muscle Defense(TM) to Its GLP-1 Companion Program to Combat Muscle-Mass Loss

Noom, the leading digital healthcare company, has introduced a new feature called Muscle Defense™ to its GLP-1 Companion Program. This innovative addition aims to prevent muscle-mass loss while individuals are taking GLP-1 medications. Noom Move, an on-demand fitness offering, includes Muscle Defense™, a curated movement program developed in collaboration with FitOn, a renowned fitness platform.

Geoff Cook, the CEO of Noom, emphasized the importance of retaining muscle mass while taking powerful weight-loss medications. He highlighted the need for a comprehensive approach to health and wellness, stating that medications alone are not sufficient. The Noom GLP-1 Companion, now with Muscle Defense™, is designed to complement the medication by incorporating exercise and nutrition programs.

Noom Move offers a wide range of on-demand workouts, such as yoga, HIIT, strength training, and Pilates, led by top fitness trainers. The program aims to make exercise more accessible and enjoyable for Noom members of all fitness levels. Key features of Noom Move include seamless integration within the Noom app, personalized workout recommendations, and a supportive community for motivation.

Dr. Andreas Michaelides, Head of Psychology at Noom, emphasized the importance of building healthy habits through programs like Noom Move. By making exercise more accessible, Noom aims to increase the likelihood of success for its members in achieving better, healthier lives.

Noom Move is now available to all Noom members, including those enrolled in the GLP-1 Companion Program. Current members can access the new fitness programming directly through the Noom app, while new members can sign up through the Noom website or app to begin their wellness journey.